. 2022 Jun 15;145(7):2407–2421. doi: 10.1093/brain/awac121

Table 1.

Demographics of the 16 FOG patients

Patient	Age/ gender	DD (years)	LEDD	FOGQ	MDS-UPDRS^a	MDS-UPDRS^b	MDS-UPDRS^c	HFS voltage (V)^d	LFS voltage (V)^e	Stimulation contacts
Sub1	72/F	10	675	10	47	28	24	3.0	3.3	2–4+, 6–8+
Sub2	60/F	7	750	20	47	24	31	2.5	2.7	2–4+, 6–8+
Sub3	57/F	5	375	14	49	24	34	2.7	2.7	2–4+, 6–8+
Sub4	66/F	10	513	21	61	22	42	2.8	2.8	2–4+, 6–8+
Sub5	53/M	12	1100	24	79	25	31	2.1	1.8	3–1+, 7–5+
Sub6	70/M	12	688	17	70	37	28	2.8	2.8	2–4+, 6–8+
Sub7	73/F	9	1439	20	51	27	46	2.1	2.1	4–3+, 8–7+
Sub8	67/F	6	500	22	52	30	26	3.0	3.2	2–4+, 6–8+
Sub9	59/F	9	700	16	46	21	11	2.8	2.8	2–4+, 6–8+
Sub10	78/M	5	550	18	58	24	27	2.2	2.2	1–3+, 5–7+
Sub11	76/M	8	1351	13	41	11	10	3.0	3.2	2–4+, 6–8+
Sub12	66/F	15	669	13	55	8	21	3.5	3.5	2–4+, 6–8+
Sub13	61/M	7	1150	22	37	18	22	2.4	3.5	4–1+, 8–5+
Sub14	66/F	15	925	20	39	20	27	2.3	2.3	4–2+, 8–6+
Sub15	67/M	10	913	16	42	20	10	2.5	2.5	2–4+, 6–8+
Sub16	67/F	9	1000	15	27	5	13	3.0	3.5	1–3+, 6–8+

DD = disease duration; LEDD = levodopa equivalent daily dose; FOGQ = freezing of gait questionnaire.

^{^a}

Baseline OFF-medication score.

^{^b}

Baseline ON-medication score.

^{^c}

One month postoperative on-stimulation OFF-medication score.

^{^d}

Stimulation frequency and pulse width for HFS: 130 Hz and 60 μs.

^{^e}

Stimulation frequency and pulse width for LFS: 60 Hz and 60 μs.